While it may help reduce the sluggish feeling associated with a caloric deficit, it is not a stimulant and results can vary from person to person
Safety, tolerability, and efficacy of NLY01 in early untreated parkinsons disease: a randomised, double-blind, placebo-controlled trial
A mixed meal tolerance test (MMTT) is not often needed to confirm the diagnosis but can be helpful in cases with a less clear presentation by demonstrating the typical glucose excursions and insulin hypersecretion seen in PBH
By six months, testosterone signaling typically stabilizes, and long-term benefits become clearer
The condition develops when stomach acid frequently flows back into the esophagus, creating that familiar burning sensation millions of Canadians experience regularly
The FDA approved Foundayo (orforglipron) on April 1, 2026